Boston Scientific Corp
NYSE: BSX
$90.00
-$1.50 (-1.6%)
Closing Price on November 22, 2024
BSX Articles
Generally speaking, we do not like to bring CEOs back from a past "list of CEOs to go." James Tobin of Boston Scientific Corp. (NYSE: BSX) has somehow managed to hang on to his job and continue to...
Published:
Last Updated:
The Massachusetts Department of Public Health funded a study which is showing further evidence to support the use of drug eluting stents over bare metal stents in heart attack patients. This study...
Published:
Last Updated:
There are many C-Suite executive from Wall Street to main Street that didn’t exactly get their stock priorities right. Many company executives are getting margin calls and are being forced to...
Published:
Last Updated:
Gareth Roberts, CEO of Denbury Resources (NYSE:DNR) was forced to sell 513,000 shares of the company’s stock to meet a margin call "pursuant to a real estate based loan." That was about 15% of his...
Published:
Last Updated:
Today after the close, SEC Filings have shown that Boston Scientific Corp. (NYSE: BSX) co-founders have been forced to sell more common stock to meet margin calls. Unfortunately this isn’t the...
Published:
Last Updated:
The list of management screw-ups at Boston Scientific (BSX) is almost too long to number. It bought rival Guidant and added $7 billion in debt in the process. Some of Guidant’s products were not as...
Published:
Last Updated:
These are some of the downgrades and cautious analyst calls we are seeing this Wednesday morning: American Capital (ACAS) Cut To Underweight from Neutral By JP Morgan. Boston Scientific (BSX) Cut to...
Published:
According to Reuters, a Senate plan to vote on the bailout package pushed US markets up. Reuters reports that the FDIC would like to increase the value of the accounts it insures. Reuters reports...
Published:
Last Updated:
The stent business in the US has been dying and it is in trouble overseas. Stents are small mesh tubs which keep clogged arteries open. Last year, several studies showed that stents could cause...
Published:
Last Updated:
Investors have another reason to bail out of Boston Scientific (BSX). It has been in a battle with the medical research community for over a year fighting the perception that its drug-coated stents...
Published:
Last Updated:
According to Reuters, Greenspan says the housing market should bottom in 2009. Reuters writes that US auto makers are scrambling to make more fuel-efficient cars. Reuters reports that the SEC is...
Published:
Last Updated:
These are some of the top analyst Upgrades and positive calls we are seeing early this Friday morning: Boston Scientific (BSX) Started as Outperform at Piper Jaffray. Cabot Micro (CCMP) Raised to...
Published:
According to Reuters, Apple (AAPL) missed Wall St. expectations, sending the stock down by 10%. Reuters reports that American Express (AXP) profits fell on credit losses. 100 Million Americans Are...
Published:
Last Updated:
We saw another exciting week full of news for key developments in drug stocks, biotech stocks, medical device stocks, and other companies involved in various aspects of health care and medicine. ...
Published:
With the trading year almost half over and results from the first quarter out, 24/7 Wall St. has created the latest installment of its Ten Worst Managed Companies In America list. This analysis is...
Published: